Discovery and Mediclinic, two of the country’s key private sector operators, have put the brakes on plans to expand their coronavirus vaccination sites, as concern grows over looming supply constraints.

SA’s vaccination campaign launched on May 17, after delays and unexpected setbacks that included a last-minute hold on the release of Johnson & Johnson’s (J&J) single-shot jab, which was intended to be the backbone of the programme. Sites are dispensing only Pfizer’s double-shot vaccine...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.